Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS Trial.

Blood advances·2026
Same author

Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.

Journal of human immunity·2026
Same author

Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

American journal of hematology·2026
Same author

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

Blood advances·2026
Same author

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

Blood cancer journal·2026
Same author

Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.

Bone marrow transplantation·2026

Related Experiment Video

Updated: Jun 11, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial.

Asad Bashey1, Brent R Logan2, LaQuisa C Hill3

  • 1Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, United States.

Blood Advances
|June 9, 2026
PubMed
Summary

Hematopoietic stem cell transplantation outcomes are similar between matched unrelated donors and haploidentical or mismatched unrelated donors. Umbilical cord blood transplants showed inferior survival, highlighting donor selection importance.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

Related Experiment Videos

Last Updated: Jun 11, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
11:27

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

Published on: September 22, 2013

Area of Science:

  • Hematology
  • Transplantation immunology
  • Clinical research

Background:

  • Alloreactivity control is crucial for successful hematopoietic stem cell transplantation (HCT).
  • Prospective comparisons between HLA-matched unrelated donors (MUD) and alternative donor sources are limited.
  • Donor selection significantly impacts transplant outcomes.

Purpose of the Study:

  • To compare HCT outcomes using MUD versus haploidentical (HAPLO), mismatched unrelated (MMUD), and umbilical cord blood (UCB) donors.
  • To evaluate the impact of donor type on survival, relapse, treatment-related mortality (TRM), and graft-versus-host disease (GVHD).
  • To inform donor selection strategies for patients lacking matched sibling donors.

Main Methods:

  • BMT CTN 1702 trial prospectively assigned patients without matched sibling donors to MUD or center's preferred alternative donor (HAPLO, MMUD, UCB).
  • Outcomes were compared between donor groups using multivariate analysis, adjusting for covariates.
  • Post-transplant cyclophosphamide (PTCy) use was recorded and analyzed.

Main Results:

  • Survival was significantly lower for UCB recipients compared to MUD, but not different for HAPLO or MMUD recipients.
  • UCB recipients had inferior TRM and disease-free survival (DFS) compared to MUD.
  • In PTCy patients, HAPLO and MMUD were associated with increased acute and chronic GVHD compared to MUD.

Conclusions:

  • Haploidentical and mismatched unrelated donors may be effective alternatives to MUD, expediting transplantation when MUD are unlikely.
  • Umbilical cord blood transplantation is associated with poorer outcomes compared to MUD, HAPLO, and MMUD.
  • Donor selection strategies should consider donor type, patient factors, and GVHD prophylaxis.